January 31st 2012
January 2012 Shareholder Letter
AmpliPhi Biosciences has released its first Shareholder Letter for 2012, including an update from President & CEO Philip Young.
The letter is available in PDF format on our website.
Events
May 09th 2012
Prof. Mark Enright “Taking a Zero Tolerance Approach to Preventable Surgical Site Infection”
MoreApril 17th 2012
Dr. David Harper at the CHI Antibacterial Drug Development Meeting
MoreMarch 26th 2012
Dr. David Harper at Society for General Microbiology Spring Conference 2012
MoreMarch 12th 2012
Professor Mark Enright to present at University of Bath
MoreMarch 12th 2012
Professor Mark Enright to present at University of Bath
More